MAP2K2 (Ab-394) Antibody

What is MAP2K2 and what role does it play in cellular signaling?

MAP2K2 (also known as MEK2, MKK2, or MAPKK2) is a dual specificity protein kinase that belongs to the MAP kinase kinase family. It functions as a critical component in the MAPK/ERK signaling cascade by:

• Catalyzing the concomitant phosphorylation of threonine and tyrosine residues in a Thr-Glu-Tyr sequence located in MAP kinases

• Activating ERK1 and ERK2 MAP kinases, which regulate cell proliferation, differentiation, and survival

• Activating BRAF in a KSR1 or KSR2-dependent manner by binding to these proteins and releasing inhibitory intramolecular interactions

The MAPK pathway plays fundamental roles in various cellular processes, and dysregulation of this pathway is implicated in numerous pathological conditions, particularly cancer. Genes associated with MAPK signaling have been strongly implicated in LRRK2 function, with research showing that knockdown of MAPK signaling genes, including mek-2 (MAP2K2), affects neuronal processes relevant to Parkinson's disease .

What is the specificity of MAP2K2 (Ab-394) Antibody?

The MAP2K2 (Ab-394) Antibody specifically detects endogenous levels of MEK2 protein only when phosphorylated at Threonine 394. According to product specifications, this antibody:

• Is generated using synthetic phosphopeptides derived from the region surrounding Thr394 of human MEK2

• Is affinity-purified using sequential epitope-specific chromatography

• Shows reactivity with human, mouse, and rat samples

• Does not cross-react with other proteins when properly validated

For optimal specificity confirmation, researchers should include appropriate controls in their experiments, such as phosphatase-treated samples or MAP2K2 knockdown controls.

What applications is MAP2K2 (Ab-394) Antibody validated for?

The antibody has been validated for multiple research applications with the following recommended dilutions:

These applications enable researchers to detect and quantify MAP2K2 phosphorylation across various experimental systems .

How should MAP2K2 (Ab-394) Antibody be stored for optimal stability?

For maximum stability and retention of activity:

• Store at -20°C for long-term preservation (recommended by most manufacturers)

• Some protocols also suggest -80°C storage as an alternative

• The antibody is typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

• Avoid repeated freeze-thaw cycles by preparing small aliquots upon receipt

• For short-term use (within a few weeks), storage at 4°C is acceptable

Following these storage guidelines will help maintain antibody performance over time.

How does phosphorylation at Threonine 394 affect MAP2K2 activity and structure?

Phosphorylation at Threonine 394 is a critical regulatory event for MAP2K2 function that affects the protein in several ways:

• It induces conformational changes that expose the catalytic site and enhance kinase activity

• This phosphorylation is part of a sequential activation process in the MAPK pathway

• T394 phosphorylation increases the affinity of MAP2K2 for its downstream targets (primarily ERK1/2)

• The phosphorylation facilitates protein-protein interactions with scaffolding proteins that are essential for efficient signal transduction

Research demonstrates that this phosphorylation site is critical in multiple disease contexts, particularly in cancer. For example, in gastric cancer, circMAP2K2 regulates the PCBP1/GPX1 axis through proteasome-mediated degradation, which further activates the AKT/GSK3β/EMT signaling pathway, enhancing cancer cell proliferation and metastasis .

What methodological considerations are important when using MAP2K2 (Ab-394) Antibody in Western blotting?

For optimal Western blot results with phospho-specific MAP2K2 antibodies, researchers should consider the following methodological approaches:

• Sample preparation:

  • Harvest cells/tissues rapidly to preserve phosphorylation status

  • Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) in all buffers

  • Use appropriate lysis buffers (e.g., RIPA buffer supplemented with protease inhibitors)

• Gel electrophoresis and transfer:

  • Expected molecular weight of MAP2K2 is approximately 44 kDa

  • Use 10-12% polyacrylamide gels for optimal resolution

  • Consider wet transfer methods for more consistent results with phospho-epitopes

• Blocking and antibody incubation:

  • Block with 5% BSA in TBST rather than milk (milk contains phospho-proteins that may increase background)

  • Recommended primary antibody dilution: 1:500-1:2000

  • Incubate overnight at 4°C with gentle agitation

• Controls and validation:

  • Include positive control (e.g., HepG2 cell lysate has been identified as a positive sample)

  • Run a parallel blot with total MAP2K2 antibody for normalization

  • Consider including phosphatase-treated samples as negative controls

• Detection considerations:

  • Enhanced chemiluminescence (ECL) or fluorescence-based detection systems are both suitable

  • Avoid over-exposure which can mask differences in phosphorylation levels

These methodological considerations will help ensure specific and reproducible detection of phosphorylated MAP2K2.

How can MAP2K2 (Ab-394) Antibody be utilized in cancer research applications?

MAP2K2 phosphorylation plays significant roles in cancer biology, making the phospho-specific antibody valuable for several research applications:

• Profiling MAPK pathway activation across cancer types:

  • Use the antibody to assess phospho-MAP2K2 levels in cancer cell lines and patient samples

  • Compare phosphorylation profiles between tumor and adjacent normal tissues

  • Correlate phosphorylation status with cancer subtypes or clinical outcomes

• Monitoring therapeutic responses:

  • Evaluate the efficacy of MEK inhibitors by measuring changes in MAP2K2 phosphorylation

  • Conduct time-course experiments to determine inhibition dynamics

  • Assess rebound activation following drug treatment

• Investigating resistance mechanisms:

  • Compare phospho-MAP2K2 levels in drug-sensitive versus resistant cancer cells

  • Identify bypass mechanisms through combined analysis with other pathway markers

• Studying pathway cross-talk:

  • Analyze interactions between MAPK and other pathways (e.g., PI3K/AKT)

  • Receptor tyrosine kinase (RTK) signaling often converges on the MAPK pathway, with research showing that RTK activation in various cancers leads to MAP2K2 phosphorylation and downstream effects

Recent research using phospho-MAP2K2 detection has revealed important insights in gastric cancer, where circMAP2K2 silencing decreases cancer cell proliferation and metastasis . Additionally, in pediatric acute myeloid leukemia, MAP2K2 pathway activation is associated with specific molecular categories that influence treatment response .

What experimental approaches can be used to validate the specificity of MAP2K2 (Ab-394) Antibody?

Rigorous validation of antibody specificity is crucial for experimental reliability. For MAP2K2 (Ab-394) Antibody, consider these validation approaches:

• Phosphatase treatment validation:

  • Divide samples and treat one portion with lambda phosphatase

  • The phospho-specific signal should significantly decrease or disappear after phosphatase treatment

• Genetic validation:

  • Use MAP2K2 knockdown (siRNA, shRNA) or knockout (CRISPR-Cas9) systems

  • The phospho-specific signal should be substantially reduced or eliminated

• Site-directed mutagenesis:

  • Express wild-type MAP2K2 and T394A mutant constructs

  • The antibody should detect wild-type but not the T394A mutant protein

• Pathway modulation:

  • Treat cells with MEK inhibitors to reduce phosphorylation

  • Stimulate cells with growth factors or serum to increase phosphorylation

  • Monitor signal changes that correspond to expected pathway dynamics

• Peptide competition:

  • Pre-incubate the antibody with the phospho-peptide immunogen

  • This should block specific binding and eliminate target signals

• Cross-reactivity assessment:

  • Test for potential cross-reactivity with closely related proteins, especially MAP2K1/MEK1

  • Evaluate specificity across different species when working with non-human samples

• Multi-method confirmation:

  • Compare results across different techniques (WB, IHC, IF)

  • Consistent results across methods increase confidence in specificity

These validation steps ensure that experimental results accurately reflect MAP2K2 phosphorylation status.

How can MAP2K2 (Ab-394) Antibody be used in Proximity Ligation Assays to study protein phosphorylation?

Proximity Ligation Assay (PLA) is a powerful technique for detecting protein modifications in situ with high sensitivity. For phosphorylation studies using MAP2K2 (Ab-394) Antibody:

• Antibody pairing strategy:

  • Use phospho-MAP2K2 (T394) rabbit polyclonal antibody paired with a total MAP2K2 mouse monoclonal antibody

  • This dual recognition approach allows visualization of individual phosphorylated protein molecules

• Experimental protocol considerations:

  • Follow established PLA protocols with optimized antibody dilutions (approximately 1:1200 for rabbit polyclonal and 1:50 for mouse monoclonal antibodies)

  • Include proper positive and negative controls to establish assay specificity

• Signal analysis and interpretation:

  • Each red dot in the resulting images represents a single phosphorylated MAP2K2 protein

  • Analyze images using appropriate software (e.g., BlobFinder from Uppsala University)

  • Quantify dots per cell to compare phosphorylation levels across experimental conditions

• Advanced applications:

  • Combine with other markers to study spatial distribution of phosphorylated MAP2K2

  • Perform time-course experiments to track phosphorylation dynamics

  • Investigate co-localization with interacting proteins

As demonstrated in product information from Abnova, PLA using dual recognition antibody pairs against MAP2K2 and phospho-MAP2K2 (T394) can effectively visualize individual phosphorylated proteins within cells .

What research approaches can be used to study MAP2K2 phosphorylation in neurodegenerative disease models?

MAP2K2 phosphorylation plays important roles in neuronal function and neurodegenerative diseases:

• Parkinson's disease models:

  • Research has implicated MAP2K2 (mek-2) in LRRK2 function and dopaminergic neuron survival

  • Knockdown of MAP2K signaling genes affects neuronal processes relevant to Parkinson's disease pathology

  • Experimental approaches should examine phospho-MAP2K2 levels in LRRK2 wild-type versus mutant systems

• Methodological considerations:

  • Primary neuronal cultures provide controlled systems for studying phosphorylation dynamics

  • Brain tissue analysis requires careful preservation of phosphorylation status during processing

  • Consider region-specific analysis given the heterogeneity of brain pathology

• Experimental designs:

  • Compare phospho-MAP2K2 levels between disease models and controls

  • Assess the effects of neuroprotective agents on MAP2K2 phosphorylation

  • Investigate the impact of oxidative stress or other disease-relevant stimuli on phosphorylation patterns

• Combined approaches:

  • Use phospho-MAP2K2 detection alongside markers of neuronal health/damage

  • Correlate phosphorylation patterns with behavioral or functional outcomes in animal models

  • Integrate with other pathway analyses to understand context-specific signaling

These approaches can help elucidate the role of MAP2K2 phosphorylation in neurodegeneration and potentially identify therapeutic targets.

How do different experimental conditions affect the detection of MAP2K2 phosphorylation?

The detection of MAP2K2 phosphorylation can vary significantly depending on experimental conditions:

• Cell culture considerations:

  • Serum starvation followed by stimulation enhances detectable phosphorylation

  • Cell density affects basal phosphorylation levels

  • Cell type-specific differences in pathway activation require protocol optimization

• Tissue sample considerations:

  • Rapid preservation is crucial to maintain phosphorylation status

  • Flash freezing or immediate fixation helps prevent phosphatase activity

  • Embedding and sectioning protocols need optimization for phospho-epitope preservation

• Treatment conditions:

  • Growth factor stimulation typically induces rapid MAP2K2 phosphorylation (minutes to hours)

  • Different stimuli (EGF, FGF, serum) may induce variable phosphorylation patterns

  • Inhibitor treatments should include appropriate time points based on compound pharmacokinetics

• Buffer composition effects:

  • Phosphatase inhibitor cocktail composition significantly impacts results

  • Detergent type and concentration affect phospho-epitope accessibility

  • pH conditions influence antibody-epitope interactions

• Detection method considerations:

  • Fluorescence-based methods may offer better quantification than colorimetric approaches

  • Signal amplification strategies can improve detection sensitivity

  • Background reduction techniques vary by experimental system

Understanding these variables and optimizing conditions for specific experimental systems is essential for reliable phospho-MAP2K2 detection.

What technical challenges might researchers face when studying MAP2K2 phosphorylation in multi-protein complexes?

Studying MAP2K2 as part of multi-protein complexes presents several technical challenges:

• Complex preservation issues:

  • Standard lysis conditions may disrupt protein-protein interactions

  • Phosphorylation status can be altered during sample processing

  • Buffer optimization is critical (salt concentration, detergent type, pH)

• Co-immunoprecipitation considerations:

  • Phospho-epitopes may be masked in protein complexes

  • Antibody binding might disrupt complex formation

  • Pre-clearing protocols need optimization to reduce non-specific binding

• Crosslinking approaches:

  • Chemical crosslinking can stabilize transient interactions

  • Crosslinker concentration and incubation time require optimization

  • Crosslinking may affect phospho-epitope recognition by antibodies

• Analytical challenges:

  • Distinguishing direct versus indirect interactions requires careful controls

  • Accounting for the dynamic nature of complex formation necessitates time-course experiments

  • Heterogeneity in complex composition requires single-cell or advanced fractionation approaches

• Validation strategies:

  • Reciprocal immunoprecipitation with different complex components

  • Mass spectrometry confirmation of complex composition

  • Functional validation through activity assays

To address these challenges, researchers should conduct preliminary optimization experiments, include appropriate controls, and consider complementary approaches to verify results.